Variant report

Variant	esv3416192
Chromosome Location	chr3:47014913-47017316
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:82)
CpG islands
(count:61)
Chromatin interactive
region (count:4)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:82 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr3:47016208-47016563	HepG2	liver:	n/a	n/a
2	BCLAF1	chr3:47015943-47016370	GM12878	blood:	n/a	chr3:47016136-47016145
3	CEBPB	chr3:47016321-47016538	HepG2	liver:	n/a	n/a
4	CEBPB	chr3:47016176-47016646	HepG2	liver:	n/a	n/a
5	CEBPB	chr3:47016338-47016518	HepG2	liver:	n/a	n/a
6	CEBPB	chr3:47016272-47016611	K562	blood:	n/a	n/a
7	CEBPB	chr3:47016240-47016615	HepG2	liver:	n/a	n/a
8	CEBPB	chr3:47016377-47016534	Hela-S3	cervix:	n/a	n/a
9	CEBPD	chr3:47016273-47016578	HepG2	liver:	n/a	n/a
10	CHD1	chr3:47015835-47016527	GM12878	blood:	n/a	n/a
11	EBF1	chr3:47015985-47016241	GM12878	blood:	n/a	n/a
12	ELF1	chr3:47015580-47015735	K562	blood:	n/a	chr3:47015640-47015653
13	ELK1	chr3:47016449-47016471	GM12878	blood:	n/a	n/a
14	EP300	chr3:47015904-47016378	GM12878	blood:	n/a	chr3:47016124-47016138
15	EP300	chr3:47016300-47016596	HepG2	liver:	n/a	chr3:47016553-47016567
16	EP300	chr3:47016189-47016644	HepG2	liver:	n/a	chr3:47016553-47016567
17	FOXA1	chr3:47016255-47016678	HepG2	liver:	n/a	n/a
18	FOXA1	chr3:47016270-47016599	HepG2	liver:	n/a	n/a
19	FOXA2	chr3:47016251-47016577	HepG2	liver:	n/a	n/a
20	GATA3	chr3:47015768-47015939	SH-SY5Y	brain:	n/a	n/a
21	HDAC2	chr3:47016301-47016602	HepG2	liver:	n/a	n/a
22	HEY1	chr3:47016309-47016627	HepG2	liver:	n/a	n/a
23	HEY1	chr3:47016308-47016679	HepG2	liver:	n/a	n/a
24	HNF4A	chr3:47016262-47016648	HepG2	liver:	n/a	chr3:47016456-47016471
25	HNF4A	chr3:47016279-47016649	HepG2	liver:	n/a	chr3:47016456-47016471
26	HNF4G	chr3:47016269-47016581	HepG2	liver:	n/a	n/a
27	IKZF1	chr3:47015984-47016506	GM12878	blood:	n/a	n/a
28	JUN	chr3:47016388-47016604	HepG2	liver:	n/a	n/a
29	JUN	chr3:47017249-47018775	K562	blood:	n/a	chr3:47018623-47018634 chr3:47018622-47018630 chr3:47018620-47018632
30	JUND	chr3:47016290-47016624	HepG2	liver:	n/a	n/a
31	MTA3	chr3:47015987-47016441	GM12878	blood:	n/a	n/a
32	MTA3	chr3:47015853-47016466	GM12878	blood:	n/a	n/a
33	MXI1	chr3:47015856-47016448	GM12878	blood:	n/a	n/a
34	NFIC	chr3:47016256-47016589	HepG2	liver:	n/a	n/a
35	NFYB	chr3:47016252-47016492	GM12878	blood:	n/a	chr3:47016317-47016331 chr3:47016316-47016331
36	PAX5	chr3:47017279-47017487	GM12878	blood:	n/a	n/a
37	POLR2A	chr3:47016169-47016355	K562	blood:	n/a	n/a
38	POLR2A	chr3:47015223-47016937	GM12878	blood:	n/a	n/a
39	POLR2A	chr3:47015715-47015800	K562	blood:	n/a	n/a
40	POLR2A	chr3:47014832-47015429	K562	blood:	n/a	n/a
41	POLR2A	chr3:47016350-47016994	HepG2	liver:	n/a	n/a
42	POLR2A	chr3:47015781-47016646	GM12892	blood:	n/a	n/a
43	POLR2A	chr3:47016211-47016688	HepG2	liver:	n/a	n/a
44	POLR2A	chr3:47015857-47015982	HUVEC	blood vessel:	n/a	n/a
45	POLR2A	chr3:47016915-47017098	K562	blood:	n/a	n/a
46	POLR2A	chr3:47015759-47016586	GM12892	blood:	n/a	n/a
47	POLR2A	chr3:47016144-47016168	K562	blood:	n/a	n/a
48	POLR2A	chr3:47016081-47016671	HepG2	liver:	n/a	n/a
49	POLR2A	chr3:47016451-47016538	HUVEC	blood vessel:	n/a	n/a
50	POLR2A	chr3:47016182-47016637	GM12892	blood:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:47016537-47016587	HepG2	liver:	n/a
2	chr3:47016537-47016587	HCT-116	colon:	n/a
3	chr3:47016537-47016587	NHBE	bronchial:	n/a
4	chr3:47016537-47016587	AG04449	skin:	fetal
5	chr3:47016537-47016587	GM12892	blood:	n/a
6	chr3:47016537-47016587	Jurkat	blood:	n/a
7	chr3:47016537-47016587	ECC-1	luminal epithelium:	n/a
8	chr3:47016537-47016587	AG04450	lung:	fetal
9	chr3:47016537-47016587	PFSK-1	brain:	n/a
10	chr3:47016537-47016587	Caco-2	colon:	n/a
11	chr3:47016537-47016587	NT2-D1	testis:	n/a
12	chr3:47016537-47016587	CMK	blood:	n/a
13	chr3:47016537-47016587	NH-A	brain:	n/a
14	chr3:47016537-47016587	HL-60	blood:	n/a
15	chr3:47016537-47016587	A549	lung:	n/a
16	chr3:47016537-47016587	AG10803	skin:	n/a
17	chr3:47016537-47016587	HCM	heart:	n/a
18	chr3:47016537-47016587	HPAEpiC	pulmonary alveolar:	n/a
19	chr3:47016537-47016587	HAEpiC	amniotic membrane:	n/a
20	chr3:47016537-47016587	NB4	blood:	n/a
21	chr3:47016537-47016587	SK-N-SH_RA	brain:	n/a
22	chr3:47016537-47016587	BJ	skin:	n/a
23	chr3:47016537-47016587	HCF	heart:	n/a
24	chr3:47016537-47016587	U87	brain:	n/a
25	chr3:47016537-47016587	HRPEpiC	eye:	n/a
26	chr3:47016537-47016587	MCF-7	breast:	n/a
27	chr3:47016537-47016587	PrEC	prostate:	n/a
28	chr3:47016537-47016587	SK-N-SH	brain:	n/a
29	chr3:47016537-47016587	Hela-S3	cervix:	n/a
30	chr3:47016537-47016587	AoSMC	blood vessel:	n/a
31	chr3:47016537-47016587	GM19239	blood:	n/a
32	chr3:47016537-47016587	BE2_C	brain:	n/a
33	chr3:47016537-47016587	NHDF-neo	bronchial:	n/a
34	chr3:47016537-47016587	IMR90	lung:	fetal
35	chr3:47016537-47016587	H1-hESC	embryonic stem cell:	embryo
36	chr3:47016537-47016587	PANC-1	pancreas:	n/a
37	chr3:47016537-47016587	Hepatocyte	liver:	n/a
38	chr3:47016537-47016587	GM12891	blood:	n/a
39	chr3:47016537-47016587	HUVEC	blood vessel:	n/a
40	chr3:47016537-47016587	SK-N-MC	brain:	n/a
41	chr3:47016537-47016587	HRCEpiC	kidney:	n/a
42	chr3:47016537-47016587	SAEC	small airway:	n/a
43	chr3:47016537-47016587	LNCaP	prostate:	n/a
44	chr3:47016537-47016587	HEEpiC	esophagus:	n/a
45	chr3:47016537-47016587	ovcar-3	ovarian:	n/a
46	chr3:47016537-47016587	GM06990	blood:	n/a
47	chr3:47016537-47016587	HNPCEpiC	eye:	n/a
48	chr3:47016537-47016587	AG09309	skin:	n/a
49	chr3:47016537-47016587	K562	blood:	n/a
50	chr3:47016537-47016587	AG09319	gingival:	n/a

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:47011340..47013025-chr3:47015501..47017285,2	MCF-7	breast:
2	chr3:47016936..47018509-chr3:47322606..47324747,2	K562	blood:
3	chr3:46959018..46961280-chr3:47014684..47016373,2	MCF-7	breast:
4	chr3:47016641..47019456-chr3:47138519..47140806,2	K562	blood:

No data

Variant related genes	Relation type
NBEAL2	TF binding region
NBEAL2	CpG island
ENSG00000114648	chromatin interactions
ENSG00000088727	chromatin interactions
ENSG00000181555	chromatin interactions

Extended variants
information (count: 100 )
Associated
traits (count: 99 )

Variant overlapped rSNPs/rCNVs (count:100 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs528002530	chr3:47014924-47014925	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs144297966	chr3:47014948-47014949	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs148711762	chr3:47014949-47014950	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs546474012	chr3:47014953-47014954	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs182515142	chr3:47014976-47014977	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs78474094	chr3:47015000-47015001	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs376150243	chr3:47015019-47015020	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs187980386	chr3:47015044-47015045	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs571414355	chr3:47015093-47015094	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs538709026	chr3:47015143-47015144	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs11715389	chr3:47015196-47015197	Weak transcription Strong transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs193095476	chr3:47015199-47015200	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs533965789	chr3:47015200-47015201	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs555406805	chr3:47015229-47015230	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs573866964	chr3:47015231-47015232	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs184849263	chr3:47015257-47015258	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs531971549	chr3:47015258-47015259	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs577820998	chr3:47015270-47015271	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs146392938	chr3:47015305-47015306	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs572300459	chr3:47015340-47015341	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs527915590	chr3:47015374-47015375	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs189370030	chr3:47015389-47015390	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs368639926	chr3:47015392-47015393	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs531984895	chr3:47015424-47015425	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs139733529	chr3:47015425-47015426	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs546090219	chr3:47015438-47015439	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs191900947	chr3:47015439-47015440	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs564396159	chr3:47015448-47015449	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs531743670	chr3:47015485-47015486	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs547511084	chr3:47015488-47015489	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs184421151	chr3:47015555-47015556	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs549938101	chr3:47015606-47015607	Weak transcription Strong transcription Genic enhancers Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs144514137	chr3:47015630-47015631	Weak transcription Strong transcription Genic enhancers Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs562101010	chr3:47015660-47015661	Weak transcription Strong transcription Genic enhancers Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs146595614	chr3:47015725-47015726	Weak transcription Strong transcription Genic enhancers Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs114116002	chr3:47015726-47015727	Weak transcription Strong transcription Genic enhancers Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs538096358	chr3:47015791-47015792	Weak transcription Strong transcription Genic enhancers Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs141054585	chr3:47015812-47015813	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs529409788	chr3:47015864-47015865	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs189444501	chr3:47015891-47015892	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs149686298	chr3:47015894-47015895	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs530746882	chr3:47015902-47015903	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs80257961	chr3:47015945-47015946	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs369693277	chr3:47016003-47016004	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
45	rs148821863	chr3:47016023-47016024	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
46	rs139736791	chr3:47016058-47016059	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
47	rs200472612	chr3:47016059-47016060	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
48	rs67376369	chr3:47016060-47016061	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
49	rs58301635	chr3:47016061-47016062	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
50	rs201109571	chr3:47016062-47016063	Weak transcription Genic enhancers Strong transcription Enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:99)

Disease	PMID	Source
Lynch syndrome	18415027	CNVD
Renal cell carcinoma	18592004	CNVD
Acute myeloid leukemia	20729466	CNVD
Urothelial carcinoma	18382360	CNVD
Melanoma	18172304	CNVD
Cervical cancer	21062161	CNVD
Hirschsprung''s Disease	21712996	CNVD
Glioblastoma multiforme	21080181	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Insulin resistance	16721378	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Oral cancer	19627613	CNVD
Renal cell carcinoma	19461508	CNVD
Epithelial cancer	22065749	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Acute myeloid leukemia	16864856	CNVD
Liposarcoma	21253554	CNVD
Basal cell lymphoma	21115979	CNVD
Endometrial cancer	22040021	CNVD
Pancreatic endocrine tumor	20981439	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Oral cancer	21386901	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Retinoblastoma	21504564	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	21668985	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Esophageal cancer	20955586	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Breast cancer	17133270	CNVD
Uveal melanoma	20484589	CNVD
Autism	22495311	CNVD
Melanoma	20688739	CNVD
Acute myeloid leukemia	21251322	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21183584	CNVD
Kartagener syndrome	16639409	CNVD
Biliary cancer	19435499	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Bipolar disorder	20877625	CNVD
Bipolar disorder	21956041	CNVD
Bipolar disorder	22241247	CNVD
Biliary cancer	18923514	CNVD
Breast cancer	21509527	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	16397240	CNVD
Breast cancer	22032731	CNVD
Non-small cell lung cancer	20864512	CNVD
Colorectal cancer	16912164	CNVD
Non-small cell lung cancer	19010865	CNVD
Colorectal cancer	16272173	CNVD
Non-muscle invasive bladder neoplasm	19445696	CNVD
Acute myeloid leukemia	17268525	CNVD
Salivary gland tumor	18059337	CNVD
Gastric cancer	16891809	CNVD
Night blindness	17160897	CNVD
Cancer	17160897	CNVD
Breast cancer	20409316	CNVD
Lung cancer	17297452	CNVD
Multiple myeloma	16616336	CNVD
Effusion lymphoma	18079361	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Neuroblastoma	20406844	CNVD
Breast cancer	21785460	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	21045282	CNVD
Urothelial cell carcinoma	18451213	CNVD
Neuroblastoma	17327916	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Melanoma	17363583	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Adrenocortical carcinoma	18281524	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:450 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:47003200-47015800	Weak transcription	Fetal Brain Male	brain
2	chr3:47003200-47016800	Weak transcription	H1 Cell Line	embryonic stem cell
3	chr3:47004800-47017200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
4	chr3:47004800-47017200	Weak transcription	HUES64 Cell Line	embryonic stem cell
5	chr3:47006600-47017000	Enhancers	Primary T killer naive cells fromperipheralblood	blood
6	chr3:47007000-47017400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
7	chr3:47007200-47017400	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr3:47007600-47016200	Weak transcription	iPS-20b Cell Line	embryonic stem cell
9	chr3:47007600-47017200	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
10	chr3:47007600-47017200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
11	chr3:47007600-47017400	Weak transcription	HSMMtube	muscle
12	chr3:47008400-47015600	Weak transcription	Hela-S3	cervix
13	chr3:47009200-47017200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
14	chr3:47010600-47015400	Weak transcription	Placenta Amnion	Placenta Amnion
15	chr3:47011200-47015600	Weak transcription	HUES6 Cell Line	embryonic stem cell
16	chr3:47011200-47017200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
17	chr3:47011200-47017200	Weak transcription	Aorta	Aorta
18	chr3:47011400-47016200	Weak transcription	HMEC	breast
19	chr3:47012200-47015800	Enhancers	Primary T helper cells PMA-I stimulated	--
20	chr3:47012600-47016000	Enhancers	Primary B cells from peripheral blood	blood
21	chr3:47012800-47015800	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
22	chr3:47012800-47017200	Enhancers	Primary T helper cells fromperipheralblood	blood
23	chr3:47013000-47015600	Weak transcription	Colonic Mucosa	Colon
24	chr3:47013000-47015600	Weak transcription	Pancreatic Islets	Pancreatic Islet
25	chr3:47013000-47015800	Enhancers	Primary monocytes fromperipheralblood	blood
26	chr3:47013000-47015800	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
27	chr3:47013000-47015800	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
28	chr3:47013000-47015800	Enhancers	Liver	Liver
29	chr3:47013000-47015800	Weak transcription	Brain Germinal Matrix	brain
30	chr3:47013000-47015800	Weak transcription	Stomach Smooth Muscle	stomach
31	chr3:47013000-47015800	Enhancers	HepG2	liver
32	chr3:47013000-47015800	Weak transcription	NHDF-Ad	bronchial
33	chr3:47013000-47016200	Weak transcription	NHLF	lung
34	chr3:47013000-47016400	Weak transcription	Fetal Brain Female	brain
35	chr3:47013200-47015600	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
36	chr3:47013200-47015800	Weak transcription	Muscle Satellite Cultured Cells	--
37	chr3:47013200-47016200	Weak transcription	Osteobl	bone
38	chr3:47013200-47017400	Weak transcription	Fetal Kidney	kidney
39	chr3:47013400-47015200	Weak transcription	Right Atrium	heart
40	chr3:47013400-47015200	Weak transcription	Right Ventricle	heart
41	chr3:47013400-47015400	Weak transcription	Brain Cingulate Gyrus	brain
42	chr3:47013400-47015400	Enhancers	Monocytes-CD14+_RO01746	blood
43	chr3:47013400-47015600	Weak transcription	HUES48 Cell Line	embryonic stem cell
44	chr3:47013400-47015600	Weak transcription	Breast Myoepithelial Primary Cells	Breast
45	chr3:47013400-47015600	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
46	chr3:47013400-47015600	Weak transcription	Brain Inferior Temporal Lobe	brain
47	chr3:47013400-47015800	Enhancers	Primary T cells fromperipheralblood	blood
48	chr3:47013400-47015800	Weak transcription	Brain Anterior Caudate	brain
49	chr3:47013400-47015800	Weak transcription	Gastric	stomach
50	chr3:47013400-47015800	Weak transcription	Ovary	ovary

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links